Pembrolizumab

Keytruda 50 MG Polvo Para Concentrado Para Solucion Para Perfusion

50,0 mg polvo para concentrado para solución para perfusiónSpainWithdrawnAuthorised 30 Jul 2015

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

KeytrudaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Pembrolizumab

Keytruda 50 MG Polvo Para Concentrado Para Solucion Para Perfusion

50,0 mg polvo para concentrado para solución para perfusiónSpainWithdrawnAuthorised 30 Jul 2015

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

KeytrudaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

KeytrudaEuropean Union · Merck Sharp & Dohme B.V.

KeytrudaCroatia

KeytrudaItaly · Polvere e solvente per soluzione per infusione endovenosa · New Pharmashop S.R.L.

KeytrudaItaly · Concentrato per soluzione per infusione · Merck Sharp & Dohme B.V.

KeytrudaItaly · Polvere e solvente per soluzione per infusione endovenosa · Abacus Medicine A/S

Keytruda 25 mg/ml concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Merck Sharp & Dohme B.V.

Keytruda 395 mg oplossing voor injectieNetherlands · Oplossing voor injectie · MSD Europe Belgium SRL

Keytruda 790 mg oplossing voor injectieNetherlands · Oplossing voor injectie · MSD Europe Belgium SRL

KeytrudaNew Zealand · Inj 25 mg per ml, 4 ml vial

Keytruda®Serbia · 25mg/mL · koncentrat za rastvor za infuziju · Merck Sharp & Dohme D.O.O.

KEYTRUDA 25 mg/ml Concentrate For Solution For InfusionSaudi Arabia · MSD International GMBH T/A MSD

Keytruda Solution for Infusion 25MG/MLSingapore · 25.0 mg/mL · infusion, solution concentrate · MSD Pharma (Singapore) Pte. LTD.

KeytrudaUnited States · 100MG/4ML · Injection · MSD International Business GmbH

KeytrudaUnited States · 100MG/4ML · solution · Merck Sharp Dohme

Pembrolizumab Solution for Infusion 25mg/mLSingapore · 25.0mg/mL · infusion, solution concentrate · MSD Pharma (Singapore) Pte. LTD.

Packs

Pack	Code	Status
KEYTRUDA 50 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 15 ml	707291

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Pembrolizumab
Strength: 50,0 mg
Dosage form: polvo para concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 30 Jul 2015
Registration: 1151024001
Marketing authorisation holder: Merck Sharp & Dohme B.V.
Procedure: EU centralised
Supply: Uso Hospitalario
EU number: EU/1/15/1024

Spain

Keytruda 25 MG/ML Concentrado Para Solucion Para PerfusionPembrolizumab · 100 mg · concentrado para solución para perfusiónSpain

Keytruda 50 MG Polvo Para Concentrado Para Solucion Para PerfusionPembrolizumab · 50,0 mg · polvo para concentrado para solución para perfusiónSpain